Discontinuation report CIPRALEX MELTZ

Last updated on 2018-07-24 History
Report ID 26436
Drug Identification Number 02391457
Brand name CIPRALEX MELTZ
Common or Proper name Escitalopram
Company Name LUNDBECK CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ESCITALOPRAM
Strength(s) 20MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-06-15
Actual discontinuation date 2018-06-15
Remaining supply date 2018-06-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2600 ALFRED-NOBEL, SUITE 400
ST-LAURENT, QUEBEC
CANADA H4S 0A9
Company contact information 514-844-8515 / Canada@Lundbeck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-07-24 French Compare
v10 2018-07-24 English Compare
v9 2018-05-31 French Compare
v8 2018-05-31 English Compare
v7 2017-11-01 French Compare
v6 2017-11-01 English Compare
v5 2017-10-30 French Compare
v4 2017-10-30 English Compare
v3 2017-10-20 French Compare
v2 2017-10-20 English Compare
v1 2017-10-20 English Compare

Showing 1 to 11 of 11